OAE出版公司
期刊
会议
图书
作者:Chunfeng Qu , Zhongping Duan , Kun Chen ...
来源:[J].Hepatoma Research, 2017, Vol.3 (10)
摘要:In China, the death numbers due to primary liver cancer every year account for more than half of this disease burden worldwide. Hepatocellular carcinoma (HCC) represents the major histological type of primary liver cancer. In the Chinese population, at least 85% HCC cases are due...
作者:Leonardo G. da Fonseca , Flair José Carrilho
来源:[J].Hepatoma Research, 2019, Vol.5 (10)
摘要:Hepatocellular carcinoma (HCC) carries an unfavorable prognosis and novel therapeutic strategies are needed. Until now, only few systemic agents have improved survival in patients with advanced stage disease. Immunotherapy changed the landscape in several tumor types by producing...
作者:Jenny Yeuk-Ki Cheng , Grace Lai-Hung Wong
来源:[J].Hepatoma Research, 2017, Vol.3 (8)
摘要:Liver fibrosis is the center of diagnosis and management of essentially all chronic liver diseases. While liver biopsy examination still has a role in diagnosis and drug development, it is replaced by non-invasive assessments of liver biopsy in majority of the clinical scena...
作者:Paola Guerriero , Farzaneh Moshiri , Laura Lupini ...
来源:[J].Hepatoma Research, 2019, Vol.5 (2)
摘要:Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide and despite improvement in therapeutic approaches, prognosis remains poor. This can be partly attributed to the fact that the majority of HCCs are diagnosed at intermediate or advan...
作者:Mohamed F. El-Gazzar , Mohamed Ahmed Samy Kohla , Mahmoud M. El-Sakhawy ...
来源:[J].Hepatoma Research, 2017, Vol.3 (6)
摘要:Aim: Gadobenate dimeglumine (multihance) is a contrast medium which can be used not only as an extracellular contrast agent for dynamic imaging of the liver, but also as a liver specific agent for the acquisition of hepatobiliary-phase images which are more helpful in evaluation ...
作者:Tim Link , Tomoo Iwakuma
来源:[J].Hepatoma Research, 2017, Vol.3 (6)
摘要:Liver cancer remains one of the most common human cancers with a high mortality rate. Therapies for hepatocellular carcinoma (HCC) remain ineffective, due to the heterogeneity of HCC with regard to both the etiology and mutation spectrum, as well as its chemotherapy resistant nat...
作者:Akshata Moghe , Obaid S. Shaikh
来源:[J].Hepatoma Research, 2018, Vol.4 (7)
摘要:Globally, hepatocellular carcinoma (HCC) is the second leading cause of cancer related death. Hepatitis C virus infected patients with cirrhosis or bridging fibrosis are particularly at risk. The risk is reduced among patients who achieve viral clearance with interferon-based reg...
作者:Muhammad Umar , Tayyab Saeed Akhter , Junaid Sadiq ...
来源:[J].Hepatoma Research, 2018, Vol.4 (11)
摘要:Aim: Genotype 3 is the most prevalent genotype in Pakistan. Despite a revolution in the treatment of Hepatitis C, genotype 3 is still thought to be difficult to treat genotype. The price of patent direct acting antivirals was thought to a great limiting factor especially for...
作者:Riccardo Nevola , Luca Rinaldi , Mauro Giordano ...
来源:[J].Hepatoma Research, 2018, Vol.4 (9)
摘要:Hepatocellular carcinoma (HCC) is the main tumor of the liver and is the sixth most frequently diagnosed tumor in the world. It is the evolution of chronic hepatic injury secondary to different etiologies. Chronic hepatitis B virus and hepatitis C virus infection, chronic alcohol...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×